Cambria Cannabis ETF Stock Forecast, Price & News

Wall Street analysts have given Cambria Cannabis ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cambria Cannabis ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Cambria Cannabis ETF's stock was trading at $10.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TOKE shares have increased by 41.6% and is now trading at $14.46.
View which stocks have been most impacted by COVID-19.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambria Cannabis ETF investors own include AT&T (T), BP (BP), Corning (GLW), GrowGeneration (GRWG), Lumen Technologies (LUMN), AdvisorShares Pure US Cannabis ETF (MSOS), Rocky Mountain High Brands (RMHB), Agritek (AGTK), AbbVie (ABBV) and Bank of America (BAC).

Cambria Cannabis ETF trades on the BATS under the ticker symbol "TOKE."

Shares of TOKE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TOKE stock can currently be purchased for approximately $14.46.